Cargando…
Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
BACKGROUND AIMS: Mesenchymal stromal cell (MSC) delivery of pro-apoptotic tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is an attractive strategy for anticancer therapy. MSCs expressing full-length human TRAIL (flT) or its soluble form (sT) have previously been shown to be ef...
Autores principales: | Yuan, ZhengQiang, Kolluri, Krishna K., Sage, Elizabeth K., Gowers, Kate H.C., Janes, Sam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503823/ https://www.ncbi.nlm.nih.gov/pubmed/25888191 http://dx.doi.org/10.1016/j.jcyt.2015.03.603 |
Ejemplares similares
-
TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2017) -
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
por: Yuan, Zhengqiang, et al.
Publicado: (2016) -
Genetically modified mesenchymal stromal cells in cancer therapy
por: Sage, Elizabeth K., et al.
Publicado: (2016) -
Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
por: Kolluri, Krishna K., et al.
Publicado: (2013) -
Optimized isolation and expansion of human airway epithelial basal cells from endobronchial biopsy samples
por: Gowers, Kate H.C., et al.
Publicado: (2017)